Jolie Siegel - Net Worth and Insider Trading

Jolie Siegel Net Worth

The estimated net worth of Jolie Siegel is at least $0 dollars as of 2024-06-21. Jolie Siegel is the Chief Legal Officer of C4 Therapeutics Inc and owns about 0 shares of C4 Therapeutics Inc (CCCC) stock worth over $0. Details can be seen in Jolie Siegel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jolie Siegel has not made any transactions after 2021-09-10 and currently still holds the listed stock(s).

Transaction Summary of Jolie Siegel

To

Jolie Siegel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jolie Siegel owns 2 companies in total, including C4 Therapeutics Inc (CCCC) , and Neon Therapeutics Inc (NTGN) .

Click here to see the complete history of Jolie Siegel’s form 4 insider trades.

Insider Ownership Summary of Jolie Siegel

Ticker Comapny Transaction Date Type of Owner
CCCC C4 Therapeutics Inc 2021-09-10 Chief Legal Officer
NTGN Neon Therapeutics Inc 2020-05-06 VP & General Counsel

Jolie Siegel Latest Holdings Summary

Jolie Siegel currently owns a total of 1 stock. Jolie Siegel owns 0 shares of C4 Therapeutics Inc (CCCC) as of September 10, 2021, with a value of $0.

Latest Holdings of Jolie Siegel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CCCC C4 Therapeutics Inc 2021-09-10 0 4.05 0

Holding Weightings of Jolie Siegel


Jolie Siegel Form 4 Trading Tracker

According to the SEC Form 4 filings, Jolie Siegel has made a total of 2 transactions in C4 Therapeutics Inc (CCCC) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in C4 Therapeutics Inc is the sale of 12,500 shares on September 10, 2021, which brought Jolie Siegel around $625,000.

Insider Trading History of Jolie Siegel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jolie Siegel Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jolie Siegel Ownership Network

Ownership Network List of Jolie Siegel

No Data

Ownership Network Relation of Jolie Siegel

Insider Network Chart

Jolie Siegel Owned Company Details

What does C4 Therapeutics Inc do?

Who are the key executives at C4 Therapeutics Inc?

Jolie Siegel is the Chief Legal Officer of C4 Therapeutics Inc. Other key executives at C4 Therapeutics Inc include Chief Financial Officer Kendra Adams , Chief Accounting Officer Mark Mossler , and Chief Medical Officer Leonard Reyno .

C4 Therapeutics Inc (CCCC) Insider Trades Summary

Over the past 18 months, Jolie Siegel made no insider transaction in C4 Therapeutics Inc (CCCC). Other recent insider transactions involving C4 Therapeutics Inc (CCCC) include a net purchase of 5,667 shares made by Utpal Koppikar ,

In summary, during the past 3 months, insiders sold 0 shares of C4 Therapeutics Inc (CCCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of C4 Therapeutics Inc (CCCC) were sold and 5,667 shares were bought by its insiders, resulting in a net purchase of 5,667 shares.

C4 Therapeutics Inc (CCCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

C4 Therapeutics Inc Insider Transactions

No Available Data

Jolie Siegel Mailing Address

Above is the net worth, insider trading, and ownership report for Jolie Siegel. You might contact Jolie Siegel via mailing address: C/o Neon Therapeutics, Inc., 40 Erie St., Suite 110, Cambridge Ma 02139.

Discussions on Jolie Siegel

No discussions yet.